A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo

NCT06000956 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

408

Enrollment

INDUSTRY

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

DRUG: Jitongning tablets
DRUG: a simulated agent of Jitongning tablets

Sponsor

Tasly Pharmaceutical Group Co., Ltd